Clinical Trial Update: Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma [NA]

View source ↗

Summary

This clinical trial update reports on the relationship between safety endpoints and everolimus trough blood levels in advanced renal cell carcinoma, with the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Renal Cell Carcinoma | NA | Status: TERMINATED